$MO

The article discusses the benefits of investing in companies with solid shareholder yields amid a U.S. market decline, focusing on dividends and share buybacks. It highlights four stocks—Altria Group (MO), Golub Capital BDC (GBDC), Alliance Resource Partners (ARLP), and Barings BDC (BBDC)—noting their attractive yields and favorable rankings. The piece also emphasizes the importance of sustainable cash flows and disciplined capital allocation in shareholder-return strategies.

Altria (MO) raised its guidance, citing growth in its smoke-free portfolio, pricing discipline, and regulatory developments. The company plans to expand its on! line and relaunch NJOY ACE, while maintaining profitability in smokeable products through pricing actions. Altria's stock is currently trading at $77.92, up from $72.98 pre-earnings. The company's future performance depends on regulatory trends and market share gains in reduced-risk nicotine products.

Barclays kept its Underweight rating on Altria Group but raised its price target to $60 from $58. This implies a 23.1% downside from the Oct 30 close of $78.03. Other recent analyst targets for Altria range from $72 to $83.

Altria (MO), Gilead (GILD), and ExxonMobil (XOM) reached 52-week highs after strong Q3 results. MO reported $1.52 EPS, raised guidance, and increased buybacks. GILD exceeded revenue/earnings expectations, boosting HIV growth outlook. XOM posted $4.23 EPS, raised dividend, and maintained buyback plan. All three stocks gained 1-3% on the day.

Seven of eight S&P 500 consumer staples companies beat EPS estimates in Q3 2026, with Coca-Cola (KO), Altria (MO), and Colgate-Palmolive (CL) exceeding both EPS and revenue forecasts. Mondelez (MDLZ) beat EPS but missed revenue. Coca-Cola raised FY2026 EPS growth outlook to at least 11%.

Altria (MO) reported Q3 revenue of $6.1B (+1% YoY) and EPS of $1.51 (+7% YoY), beating expectations. The company raised its full-year earnings guidance, citing strong performance. Shares rose 6% over two days and are up 33% YTD. CEO Sal Mancuso highlighted confidence in the full-year plan. Marlboro, with a 40% U.S. market share, drives most revenue. Other high-yield companies like UPS, Kraft Heinz, and General Mills face economic sensitivity and competition.

UBS kept its Buy rating on Altria Group and increased its price target to $83 from $79, suggesting a 6.4% upside from the Oct 30 close of $78.03, according to the company.

Citigroup kept its Neutral rating on Altria Group but increased its price target to $72 from $70, suggesting a 7.7% downside from the last close of $78.03.

Morgan Stanley kept its Equal-Weight rating on Altria Group but increased its price target from $71 to $77, an 8.5% rise. The new target is close to the stock's recent close of $76.75.

Altria Group's average stock price target increased from $71.8 to $72.4, with estimates ranging from $58 to $85. This implies a 6% downside from the Oct. 29 closing price. Analysts maintain a 'Hold' consensus rating, with 4 Buys, 9 Holds, and 4 Sells.